|Bid||2.9900 x 0|
|Ask||3.0000 x 0|
|Day's Range||2.9500 - 3.2000|
|52 Week Range||0.1550 - 6.3300|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||149.00|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, July 22, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its 49%-owned joint venture, PharmHouse Inc. ("PharmHouse"), has received a cultivation licence from Health Canada. PharmHouse will be immediately commencing operations in 190,000 sq. ft. of licensed nursery infrastructure and plans to ramp up the entire 1.3 million sq. ft. ultramodern greenhouse before the end of 2019 to deliver low-cost and high-quality cannabis and cannabis derivative products to the Canopy Rivers ecosystem of partners, both domestically and internationally. "This is a significant corporate milestone for Canopy Rivers.
TORONTO, July 16, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV:RIV.V - News) (OTC:CNPOF - News) today released its financial results for the three and twelve months ended March 31, 2019. The Company's audited consolidated financial statements for the twelve months ended March 31, 2019, and its full Management's Discussion and Analysis (the "MD&A") for the three and twelve months ended March 31, 2019, are available under the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com and on the Company's website at www.canopyrivers.com/financials. "It was a year full of milestones and significant achievements for Canopy Rivers," said Narbe Alexandrian, President and Chief Executive Officer of Canopy Rivers.
TORONTO , July 9, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company, YSS Corp. (" YSS ") ...
TORONTO, July 8, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (TSXV:JWCA.V - News) (OTCQX:JWCAF - News), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario.
TORONTO , July 8, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) congratulates its portfolio company TerrAscend Corp. (" TerrAscend ...
TORONTO , July 3, 2019 /CNW/ - Further to Canopy Growth Corporation's press release today, Bruce Linton has also stepped down as Chairman and Director of Canopy Rivers Inc. (the "Company" or ...
TORONTO, June 19, 2019 /CNW/ - Canopy Rivers Inc. (the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) will report its financial results for the fourth quarter and fiscal year ended March 31, 2019 before markets open on Tuesday, July 16, 2019. The Company's audited consolidated financial statements and Management's Discussion and Analysis for the three and twelve months ended March 31, 2019 will be available on the Company's profile on SEDAR at www.sedar.com and in the Investors section of the Company's website at www.canopyrivers.com. Certain preliminary financial information pertaining to the Company may also be found in the financial results released by Canopy Growth Corporation (TSX: WEED, NYSE: CGC), which are currently scheduled to be released on June 20, 2019.
TORONTO and SAN DIEGO, June 19, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers", the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) and ZeaKal, Inc. ("ZeaKal") are pleased to announce an investment and strategic collaboration between Canopy Rivers and ZeaKal, a California-based plant science innovator with proprietary technologies that sustainably increase photosynthesis, improve plant yield and enhance nutritional profiles for a variety of agricultural crops. The investment from Canopy Rivers marks another significant corporate milestone this calendar year for ZeaKal, following the February announcement of its R&D collaboration (link) with Corteva Agriscience (NYSE:CTVA), the recently spun-out and NYSE-listed agricultural science division of DowDuPont.
TORONTO , June 13, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) has granted incentive stock options under the Company's stock option ...
TORONTO, May 28, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News), (OTC:CNPOF - News) will be hosting its analyst and investor day from 1:00 p.m. to 5:00 p.m. ET today, May 28. The webcast will be available on Canopy Rivers' website immediately prior to the event at www.canopyrivers.com/investors/events. Bruce Linton, Chairman of the Board, will share his perspective on Canopy Rivers' unique value proposition. This will be followed by a presentation from senior executives addressing Canopy Rivers' priorities in support of its mission to accelerate success in the global cannabis economy.
Final 190,000 sq. ft. Greenhouse Licensed. Total of 700,000 sq. ft. of Production and Processing Infrastructure Now Fully Licensed MIRABEL, QC , May 28, 2019 /CNW/ - Les Serres Vert Cannabis Inc. ("Vert ...
TORONTO , May 23, 2019 /CNW/ - Canopy Rivers Inc. (" Canopy Rivers " or the " Company ") (TSXV: RIV) (OTC: CNPOF) today announced that it will host an analyst and investor day on Tuesday, ...
TORONTO, May 22, 2019 /CNW/ - Canopy Rivers Inc. (the "Company" or "Canopy Rivers") (TSXV:RIV.V - News) today announced the promotion of former OMERS venture capitalist and Canopy Rivers President, Mr. Narbé Alexandrian, to Chief Executive Officer of the Company, effective immediately. Bruce Linton has transitioned from his role as acting CEO and will continue to provide oversight, deal flow, strategic insight, and opportunities for collaboration and further strategic alignment with Canopy Growth in conjunction with his ongoing role as Chairman of the Canopy Rivers Board of Directors.
TORONTO, May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada.
TORONTO and PALMERSTON NORTH, New Zealand, May 15, 2019 /CNW/ - BioLumic Ltd. ("BioLumic"), creators of a sustainable ultraviolet (UV) crop yield enhancement system, and Canopy Rivers Inc. ("Canopy Rivers") (TSXV:RIV.V - News), (OTC:CNPOF - News) today announced a strategic investment from Canopy Rivers. BioLumic extended the Finistere Ventures-led Series A financing round to include Canopy Rivers' strategic investment of US$1.5 million, closing the oversubscribed round at US$6.7 million. This marks Canopy Rivers' first investment in agri-technologies, specifically focused on the promising fields of plant physiology and UV photobiology.
TORONTO, May 9, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) is pleased to announce that its portfolio company PharmHouse Inc. ("PharmHouse") has entered into a second offtake agreement (the "Agreement") with Canopy Growth Corporation ("Canopy Growth") (TSX:WEED.TO - News) (NYSE:CGC - News) for the purchase of cannabis from its 1.3 million square foot greenhouse facility upon licensing. The Agreement commits an additional 20% of PharmHouse's flowering space to Canopy Growth for the next three years, in addition to the 10% that was originally committed in May 2018.
SMITHS FALLS, ON, May 9, 2019 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX:WEED.TO - News) (NYSE:CGC - News) is pleased to announce today that has signed an offtake agreement with PharmHouse Inc. ("PharmHouse"), a 49 per cent-owned joint venture of Canopy Rivers Inc. (TSXV:RIV.V - News) (OTC:CNOPOF). Under the terms of the agreement, PharmHouse has agreed to allocate high quality cannabis flower from an additional 20 per cent of the flowering space available at its Leamington greenhouse facility over the next three years. Boasting 1.3 million square feet of greenhouse grow space, and leveraging the resources of Canopy Growth, Canopy Rivers and its joint venture partner have worked diligently since October 2018 to prepare the facility for licensing. PharmHouse will leverage Canopy Growth's genetics – selected and supplied by the Company – and flower will be returned to the Company to be sold under Canopy Growth's diverse brands and banners. Under the terms of the new offtake agreement, PharmHouse is committed to producing GMP-certified, high quality cannabis flower within 18 months of its cultivation license and the flower must comply with the Company's high standards for cannabis quality.
TORONTO, May 3, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (TSXV:RIV.V - News) (OTC:CNPOF - News) congratulates its portfolio company TerrAscend Corp. ("TerrAscend") (CSE:TER.CN - News) (OTCQX:TRSSF - News) on its announcement yesterday that its facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice ("GMP") certificate in accordance with the rules governing medicinal products in the European Union ("EU"). Only medical cannabis from EU GMP certified facilities, or the equivalent, may be sold in the EU. The regulatory approach has been led by several of the larger EU countries and as such, pharmaceutical grade controls in production were an established requirement from the onset of medical cannabis legalization.
HOUSTON, TX / ACCESSWIRE / April 30, 2019 / The cannabis beauty market is just beginning to gain momentum. "There is a great deal of room for innovation in his sector, and topicals and beauty products are expected to explode with legalization and the entry of major consumer packaged goods companies," notes market research firm, The Brightfield Group. Some of the top companies benefiting from the news are The Yield Growth Corporation (CSE:BOSS)(OTCQB:BOSQF), Canopy Rivers Inc. (TSXV:RIV)(OTC:CNPOF), and Ovation Science Inc. (CSE:OVAT)(OTC:OVATF).
TORONTO, April 24, 2019 /CNW/ - TerrAscend Corp. (CSE:TER OTCQX:TRSSF) ("TerrAscend" or the "Company") today reported financial results for the fourth quarter ending December 31, 2018. Financial results and analyses are available on the Company's website (www.terrascend.com) and SEDAR (www.sedar.com). For the three months ended December 31, 2018, revenue totaled $5.0 million, up from $1.8 million in the third quarter of 2018 and $0.0 million in the fourth quarter of 2017.
PALM BEACH, Florida, April 18, 2019 /CNW/ -- It's a marriage made in heaven in POT heaven that is. In both the U.S. and Canada, the consumer demand for cannabis products continues its steady growth but one obstacle could be the unmet need for more dispensaries. The consumer demand for cannabis products exceeded even the most optimistic projections there are just not enough retail dispensaries (with sufficient supplies also but that is for another time) and Mall owners have too many stores without a tenant so, Dispensaries and Mall owners are entering into a hopefully long and mutually rewarding relationship! An industry publication recently said that, in both Canada and the U.S. "The future is very bright for property owners in North America as cannabis companies are on the hunt for cannabis retail locations." The article said that, "Cannabis retailers aren't very widespread in Canada as most provincial governments are slow to roll out the licenses needed to open the stores.
TORONTO, April 16, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers") (TSXV:RIV.V - News) and High Beauty, Inc. ("High Beauty") are pleased to announce the completion of an investment by Canopy Rivers in High Beauty, creator of industry-leading cannabis beauty brand high. Canopy Rivers has subscribed for US$2.5 million of shares in High Beauty, representing 18.4% of the company on a fully diluted basis, including additional warrant coverage. "Being supported by Canopy Rivers enables us to collaborate within the Canopy Rivers ecosystem and to focus our energy and passion on the creation of a robust new product line using cannabis-derived extracts," said Melissa Jochim, a highly successful formulator and Founder of High Beauty.
LOS ANGELES, April 12, 2019 /CNW/ --With a total of 33 states so far approving medical marijuana, yet another state appears on the road to legal medical adoption. For the first time ever, the Kentucky legislative panel has advanced a medical marijuana bill. Strong endorsement of medical marijuana legalization has added momentum to the cannabis growth and CBD derived products markets in U.S. states where companies see the trend as a next step to national growth, including providers like General Cannabis Corp (OTC:CANN - News), Canopy Rivers Inc. (TSX.V:RIV.V - News) (OTC:CNPOF - News), and MedMen Enterprises Inc. (OTC:MMNFF - News) (CSE:MMEN).
PALM BEACH, Florida, April 11, 2019 /CNW/ -- This year 2019 will be the year of maturation and expansion for the cannabis industry. A recent article in Forbes echoed this optimism: "This new year bodes well for the cannabis industry. Momentum from several major developments in 2018, including the inclusion of industrial hemp in the new farm bill and Canada's nationwide legalization, will certainly continue to fuel innovation, policy and entrepreneurship… there's a lot of enthusiasm and a general expectation that the U.S. is moving toward an end of prohibition at the federal level. It continued: "This is the year when we're going to start to see a bifurcation between companies that are solid and those that aren't.
In October 2018, Canada became the second country to ever legalize cannabis entirely, joining Uruguay on that short list. Meanwhile, globally, a string of countries such as Australia, Germany, and South Korea began accelerating their medical cannabis programs.